AOP Orphan Pharmaceuticals Aktiengesellschaft
Contact:
AOP
Phone: +43 503 72 44-24
E-Mail: olena.weissenbacher@aoporphan.com
Contact:
AOP
Phone: +43 503 72 44-24
E-Mail: olena.weissenbacher@aoporphan.com
KEYWORDS:
- JAK2
- long-acting interferon
- Polycythaemia vera
- ropeginterferon
- AOP Orphan
attachments to announcement
AOP Orphan announces positive CHMP opinion for Ropeginterferon alfa-2b/BESREMi®
back to announcementphotos
 [ download press photo ] | title: AOP Orphan Pharmaceuticals AG image text: AOP Orphan announces positive CHMP opinion for Ropeginterferon alfa-2b/BESREMi® copyright: AOP Orphan |
